homeostasis/metabolism
• streptozotocin-treated mice exhibit increased serum glucose levels that can be restored transiently to euglycemia by transplanting islet cells from Prkdcscid/Prkdcscid Tg(HLA-A2.1)1Enge Tg(B2M)55Hpl transgenic mice
• 70% of streptozotocin-treated mice transplanted with islet cells from Prkdcscid/Prkdcscid Tg(HLA-A2.1)1Enge Tg(B2M)55Hpl transgenic mice and HLA-A2 negative human peripheral blood mononuclear cells exhibit increased glucose serum levels
• however, all of streptozotocin-treated mice transplanted with islet cells from Prkdcscid/Prkdcscid Tg(HLA-A2.1)1Enge Tg(B2M)55Hpl transgenic mice and HLA-A2 positive human peripheral blood mononuclear cells exhibit euglycemia
|
immune system
• streptozotocin-treated mice transplanted with islet cells from Prkdcscid/Prkdcscid Tg(HLA-A2.1)1Enge Tg(B2M)55Hpl transgenic mice and HLA-A2 negative human peripheral blood mononuclear cells exhibit destruction of engrafted islet cells
|